We are live on
!
Find out more
PTC
Philadelphia Trust Company Portfolio holdings
AUM
$1.42B
1-Year Est. Return
43.77%
This Fund
S&P 500
This Quarter
Est. Return
+11.93%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.13B
AUM Growth
+$197M
(+21%)
Cap. Flow
+$32.7M
Cap. Flow
% of AUM
2.88%
Top 10 Holdings %
Top 10 Hldgs %
29.71%
Holding
207
New
31
Increased
81
Reduced
51
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$13.7M |
| 2 |
Medtronic
MDT
|
+$11.2M |
| 3 |
Teradyne
TER
|
+$8.87M |
| 4 |
Kohl's
KSS
|
+$7.5M |
| 5 |
Rockwell Automation
ROK
|
+$6.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RGN
REGENERX BIOPHARMACEUTICALS
RGN
|
+$60.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$14.2M |
| 3 |
Huntsman Corp
HUN
|
+$4.92M |
| 4 |
Procter & Gamble
PG
|
+$4.73M |
| 5 |
Abbott
ABT
|
+$4.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 17.16% |
| 3 | Healthcare | 15.07% |
| 4 | Communication Services | 11.69% |
| 5 | Industrials | 9.94% |
Similar funds
CBA
BC
KC
EWS
SCM
NI
QC
IHG
Philadelphia Trust Company's Q1 2019 Portfolio in Review
As of Q1 2019, Philadelphia Trust Company held 207 positions worth $1.13B, up 21% from $936M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Philadelphia Trust Company's Q1 2019 filing shows 31 new, 81 increased, 51 reduced and 7 closed positions. Its largest new stake was Teradyne: 237,280 shares worth $9.45M. The largest sale was REGENERX BIOPHARMACEUTICALS, an estimated $60.9M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Philadelphia Trust Company's largest Q1 2019 buy was Teradyne: 237,280 shares worth $9.45M.
- Philadelphia Trust Company added most to Intel in Q1 2019, an estimated $13.7M increase.
- Philadelphia Trust Company's biggest Q1 2019 reduction was REGENERX BIOPHARMACEUTICALS, cutting an estimated $60.9M.
- Philadelphia Trust Company fully exited Huntsman Corp in Q1 2019, selling an estimated $4.92M.
- Philadelphia Trust Company's ten largest holdings make up 30% of its $1.13B portfolio in Q1 2019.
- Philadelphia Trust Company opened 31 new positions and closed 7 in Q1 2019.
- Philadelphia Trust Company's portfolio value rose 21% quarter-over-quarter to $1.13B.
Based on Philadelphia Trust Company's 13F filing for Q1 2019, filed 15 May 2019.